MSInsight
Created in 2022
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
1,276Activities
Technologies
Entity types
Location
Paris, France
Paris
France
Employees
Scale: 2-10
Estimated: 6
SIREN
910844729Engaged corporates
32
6 31Added in Motherbase
1 year, 3 months ago
healthtech Value proposition
Unlocking the Power of Genomics: Advancing Cancer Care and Precision Medicine
MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status.
MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker.
We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for guiding clinical decision-making.
Microsatellite Instability, Next-Generation Sequencing, Diagnostic Test, Bioinformatics, Oncology, Precision Medicine, Hereditary Cancer, and Defective Mismatch RepairOriginal language
Unlocking the Power of Genomics: Advancing Cancer Care and Precision Medicine
MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status.
MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker.
We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for guiding clinical decision-making.
Home - MSInsight
Our mission MSInsight is empowering precision medicine in oncology by revealing actionable information on microsatellite instability - MSI - through genomic analysis. Shape the future of the diagnosis of a tumoral biomarker at the genomic level, Microsatellite Instability (MSI) Unlock a deeper and more reliable identification of MSI with genomic data from Next-Generation Sequencing Reveal
https://www.msinsight.tech/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 STATION F Startup accelerator & VC, Software Development | STATION F Startup accelerator & VC, Software Development | Other 30 Nov 2022 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 13 Mar 2024 | | |
 KPMG Consulting, audit, Accounting | KPMG Consulting, audit, Accounting | Other 30 Nov 2022 | | |
 Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Other 30 Nov 2022 | | |
 BioValley France Public business cluster, Biotechnology, French Cluster, Biotechnology Research | BioValley France Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 30 Nov 2022 | | |
 Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 30 Nov 2022 | | |
 Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 20 Oct 2023 | | |
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 6 Jul 2023 | | |
 Linksium Venture Capital and Private Equity Principals | Linksium Venture Capital and Private Equity Principals | Other 30 Nov 2022 | | |
 PULSALYS Research, Research Services | PULSALYS Research, Research Services | Other 29 Feb 2024 | | |